long intergenic non-protein coding RNA 1627Genealiases: []
Q-omics provides the consensus-scored LINC01627 profile across patient tissues and cancer cell-line models. LINC01627 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in THYM. Among the 18 cancer types available for tumor–normal comparison, LINC01627 is differentially expressed in 2, with the highest sampling consensus in THCA. Additionally, LINC01627 RNA expression shows 10,230 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight THYM, THCA, and TGCT as cancer lineages where LINC01627 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01627 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01627 survival associations across molecular data types. LINC01627 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01627 RNA expression–survival associations across cancer types. High LINC01627 expression shows unfavorable associations in THYM, UVM, UCEC, MESO and ACC, but favorable associations in LUAD. The THYM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THYM as the clearest survival context for LINC01627 RNA expression.
This table summarizes LINC01627 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01627. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01627 shows lower tumor expression in THCA and KIRC. The THCA box plot shows higher LINC01627 RNA expression in normal versus tumor tissue (log2 FC = −0.109, t-test p = .034).
This table shows molecular features associated with LINC01627 in patient tissues and cancer cell lines. In patient samples, LINC01627 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
